Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/30/2010US20100249212 Gene Silencing Using mRNA-cDNA Hybrids
09/30/2010US20100249211 N-Substituted-Aminomethylene Bridged Bicyclic Nucleic Acid Analogs
09/30/2010US20100249210 Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
09/30/2010US20100249209 Gene involved in immortalization of human cancer cell and use thereof
09/30/2010US20100249208 Novel Methods and Models for Rapid, Widespread Delivery of Genetic Material to the CNS Using Non-Viral, Cationic Lipid-Mediated Vectors
09/30/2010US20100249207 Synthesis of pyrrolidine compounds
09/30/2010US20100249206 Modified lysine-mimetic compounds
09/30/2010US20100249205 Metabolites of Wortmannin Analogs and Methods of Using Same
09/30/2010US20100249204 Calcium salts of indole derived statins
09/30/2010US20100249203 Compounds that inhibit trpv1 and uses thereof
09/30/2010US20100249202 Agent for fungal dermatitis
09/30/2010US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
09/30/2010US20100249200 Novel Compounds 569
09/30/2010US20100249198 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249196 Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine
09/30/2010US20100249195 Pyridylphenyl compounds for inflammation and immune-related uses
09/30/2010US20100249194 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
09/30/2010US20100249192 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010US20100249190 Hepatitis C Virus Inhibitors
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249188 Prediction of qt prolongation based on snp genotype
09/30/2010US20100249187 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
09/30/2010US20100249186 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
09/30/2010US20100249185 Method for inhibiting topoisomerase ii
09/30/2010US20100249184 Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interaction
09/30/2010US20100249183 Therapeutic use of n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives
09/30/2010US20100249182 Aminoquinoline derivatives, preparation method thereof and pharmaceutical composition comprising the same
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249180 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
09/30/2010US20100249179 Farnesoid X Receptor Agonists
09/30/2010US20100249178 Compositions and methods for treating middle-of-the-night insomnia
09/30/2010US20100249177 Compositions and methods for treating middle-of-the-night insomnia
09/30/2010US20100249176 Heterocycle amide t-type calcium channel antagonists
09/30/2010US20100249175 Dicationic compounds which selectively recognize G-quadruplex DNA
09/30/2010US20100249174 Ccr1 antagonists and methods of use therefor
09/30/2010US20100249173 Dihydroquinolinones as ectoparasiticides
09/30/2010US20100249172 9-chloro noscapine and its use in treating cancers, including drug-resistant cancers
09/30/2010US20100249171 Ellipticine compounds for treating obesity
09/30/2010US20100249170 Intranasal compositions
09/30/2010US20100249169 Formulations for parenteral delivery of compounds and uses thereof
09/30/2010US20100249168 Compounds and Formulations Suitable for Radical Scavenging
09/30/2010US20100249167 Alkylsulfonyl-2,3-dihydrospiro[indene-1,4'-piperidine] analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
09/30/2010US20100249165 Pdz domain modulators
09/30/2010US20100249164 Modulation of sleep with nr2b receptor antagonists
09/30/2010US20100249163 Renin inhibitors
09/30/2010US20100249162 Process for the introduction of hydroxyethoxy side chain in bosentan
09/30/2010US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
09/30/2010US20100249160 Cancer Treatment Method
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249158 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
09/30/2010US20100249157 Lpa receptor antagonist
09/30/2010US20100249156 Antiviral topical formulations in the form of a bio-adhesive gel
09/30/2010US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010US20100249154 Compositions useful for treating disorders related to trpa1
09/30/2010US20100249153 Substituted indolo-piperidine compounds
09/30/2010US20100249152 New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof
09/30/2010US20100249151 Imidazo 1, 2-a pyrimidine derivatives for the treatment of diseases such as diabetes
09/30/2010US20100249150 Stable pharmaceutical composition of freeze-dried tetrodoxin powder
09/30/2010US20100249149 Inhibitors of Protein Kinases
09/30/2010US20100249148 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
09/30/2010US20100249147 Sulfonyl-substituted 6-membered ring derivative
09/30/2010US20100249146 Heteroaryloxy quinazoline derivative
09/30/2010US20100249145 Inhibitors of VEGF Receptor and HGF Receptor Signaling
09/30/2010US20100249144 Substituted piperazines as cb1 antagonists
09/30/2010US20100249143 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds
09/30/2010US20100249142 IMIDAZOL[1,2-alpha]QUINOXALINES AND DERIVATIVES FOR THE TREATMENT OF CANCERS
09/30/2010US20100249141 Novel inhibitors of folic acid-dependent enzymes
09/30/2010US20100249140 Solid state forms of sitagliptin salts
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249138 Mpzp: a small molecule corticotropin-releasing factor type 1 receptor (crf1) antogonist
09/30/2010US20100249137 Novel sEH Inhibitors and Their Use
09/30/2010US20100249136 Organic compounds
09/30/2010US20100249135 Sulfonamides and their use as a medicament
09/30/2010US20100249134 Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina
09/30/2010US20100249133 Apoptosis promoters
09/30/2010US20100249132 Imidazole derivatives
09/30/2010US20100249131 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
09/30/2010US20100249130 Biaryl compositions and methods for modulating a kinase cascade
09/30/2010US20100249129 Compounds as cannabinoid receptor ligands
09/30/2010US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
09/30/2010US20100249127 Substituted indolo-pyridinone compounds
09/30/2010US20100249126 Pyrimidine derivatives used as pi-3-kinase inhibitors
09/30/2010US20100249125 Inhibition of prostglandin e2 receptors for the treatment of endometriosis
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100249122 Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
09/30/2010US20100249120 Substituted pyrazolo-pyrrolo-pyridine-dione compounds
09/30/2010US20100249119 Heterocyclic compound and use thereof
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249117 Factor xa inhibitors
09/30/2010US20100249116 Compositions and Methods for Treating Intoxications
09/30/2010US20100249115 Substituted heterocyclic compounds
09/30/2010US20100249114 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
09/30/2010US20100249113 Modulators of atp binding cassette transporters
09/30/2010US20100249112 Combination of chk and parp inhibitors for the treatment of cancers
09/30/2010US20100249111 Multi-ring compounds and uses thereof
09/30/2010US20100249110 Substituted pyrazolo-pyrimidine compounds
09/30/2010US20100249109 Substituted tetrahydropyrazolo-pyrido-azepine compounds
09/30/2010US20100249108 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
1 ... 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 ... 7860